How to Get Skinoren Online in Ireland

If you want to get Skinoren online in Ireland, you do not need to wait weeks for a local GP appointment or dermatologist referral. Through Hi-Doctor, you complete a quick clinical questionnaire and upload photos of your skin from home. An EU-licensed doctor reviews your submission and, when clinically appropriate, issues an official European valid electronic prescription in under 24 hours for a flat 40 € fee. You pay with zero financial risk: if our doctor determines the treatment is not suitable for you, your 40 € is refunded in full.

How it works: get your consultation in 4 steps

Getting your prescription through Hi-Doctor is entirely digital, private, and RGPD-compliant. You can complete the process in minutes from your phone or computer.

1. Complete the medical questionnaire: Answer targeted questions about your breakout patterns, skin sensitivity, past treatments, and current health status.
2. Upload skin photographs: Provide clear, well-lit photos of the affected areas so the EU doctor can evaluate lesion morphology and severity accurately.
3. Doctor clinical assessment: An EU-licensed doctor reviews your file and, when clinically appropriate, issues an official the valid electronic prescription digital prescription in under 24 hours.
4. Present at your pharmacy: Download your prescription PDF from your patient portal or email. Print it out or show it on your phone at your local pharmacy in Ireland, where the pharmacist reviews the order and may dispense azelaic acid 15% gel (Skinoren).

Who qualifies

Skinoren contains azelaic acid 15% gel and is indicated for mild-to-moderate inflammatory acne vulgaris and papulopustular rosacea. Because it is non-photosensitising and carries a very low risk of post-inflammatory hyperpigmentation, it is widely recommended for darker skin phototypes and patients who cannot tolerate retinoids.

Hi-Doctor provides consultations strictly for outpatient topical dermatology. Patients presenting with severe nodulocystic acne, extensive scarring, or systemic symptoms are out of scope and are referred directly to in-person clinical care.

Over 50,000 patients have accessed clinical care through Hi-Doctor, backed by an independent 4.8/5 Trustpilot rating.

What Skinoren actually does

Skinoren (azelaic acid 15% gel) provides a targeted dual-action mechanism against acne lesions. It acts as a comedolytic agent by normalising follicular keratinisation, which prevents dead epidermal cells from plugging pores. Simultaneously, it exerts direct antibacterial properties against Cutibacterium acnes without causing bacterial resistance.

Consistency is vital when using topical azelaic acid twice daily. Patients should anticipate a standard therapeutic timeline:

• Weeks 1–2: Skin begins adjusting to the formulation; transient tingling or dryness may occur.
• Weeks 2–6: Mild purging or cellular turnover can bring sub-surface microcomedones to the surface.
• Week 12: Meaningful clinical reduction in inflammatory papules, pustules, and redness is formally evaluated.

Side effects and when to stop

Azelaic acid 15% gel is generally gentle, but mild local cutaneous irritation is normal when initiating therapy. Most symptoms resolve within 2 to 4 weeks as your epidermal barrier adapts.

• Common initial reactions: Mild stinging, burning, itching, or superficial flaking at the application site.
• Barrier management: Apply a light, non-comedogenic moisturiser before applying Skinoren, or reduce application to once daily until tolerance develops.
• When to stop: Discontinue treatment immediately and seek urgent medical evaluation if you experience severe contact dermatitis, facial swelling, hives, or breathing difficulty.

Why Hi-Doctor vs. walking into a clinic

Booking a GP appointment in Ireland often entails long waiting times, while private dermatologists frequently have waiting lists spanning months. Hi-Doctor offers a direct, legally recognised pathway for routine dermatological prescriptions.

Prescriptions issued through Hi-Doctor use Spain's official the valid electronic prescription electronic framework, structured for cross-border recognition under Directive 2011/24/EU with mandatory fields specified by Commission Implementing Directive 2012/52/EU.